Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

RISE analyses highlight further youth vs. adult type 2 diabetes differences

Publish date:: September 25, 2019

Key clinical point: Type 2 diabetes is more aggressive in youth than adults and may need for earlier, intensive intervention.

Major finding: In youth with the incessant-increase glucose curve there was no evidence of beta-cell hypersecretion, which suggested they have more severe beta-cell dysfunction.

Study details: The Restoring Insulin SEcretion (RISE) studies: RISE Pediatric Medication Study (RISE Peds) and RISE Adult Medication Study (RISE Adult).

Disclosures: The RISE studies are sponsored by the RISE Study Group in collaboration with the National Institute of Diabetes and Digestive and Kidney Diseases. Dr. Zeitler disclosed that he had been a consultant to Boehringer-Ingelheim, Eli Lilly, Daiichi-Sankyo and Merck, Sharp & Dohme, and had received research support from Janssen. Dr. Arslanian stated that she has nothing to disclose. Dr. Khan did not provide any disclosure information.

Citation:

Arslanian S. EASD 2019, Oral presentation #S34.1; Kahn S. EASD 2019, Oral presentation #S34.3.

This Week's Must Reads

Annual WCC visits significantly limit asthma worsening,

Does daily inhaler monitoring improve asthma outcomes in children?,

More severe AD correlates with worse sleep health and attention problems in children,

COVID-19–induced drop in first measles vaccinations sparks resurgence concerns,

Shortcomings identified in study of acne videos on TikTok,

Must Reads in Diabetes

Cognitive deficits complex in youths with type 2 diabetes,

Inflammatory markers may explain COVID-19, diabetes dynamic,

Nearly one in five U.S. adolescents have prediabetes,

Ketoacidosis is on the rise in children with type 1 diabetes,

Signs of adult diabetes apparent in very young children,